The effectiveness of the Masterson curette in sampling the endometrial cavity.

L. Reddington, E. Hernandez, G. Balsara, D. Hughes, L. Anderson, Paul Heller

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The Masterson curette was used to sample the endometrial cavity of 25 women prior to scheduled hysterectomy for benign or malignant pathology. Adequate amount of tissue was obtained in 20 (87%) of 23 patients who did not have endometrial atrophy. The Masterson curettage detected all seven cases of endometrial hyperplasia or adenocarcinoma for a sensitivity of 100%. However, the Masterson curette does not sample the entire endometrial cavity. If abnormal uterine bleeding persists despite normal histology on curettings obtained with the Masterson or other endometrial sampling device, hysteroscopy is recommended.

Original languageEnglish (US)
Pages (from-to)877-880
Number of pages4
JournalJournal of the National Medical Association
Volume87
Issue number12
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Endometrial Hyperplasia
Hysteroscopy
Curettage
Uterine Hemorrhage
Hysterectomy
Atrophy
Histology
Adenocarcinoma
Pathology
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Reddington, L., Hernandez, E., Balsara, G., Hughes, D., Anderson, L., & Heller, P. (1995). The effectiveness of the Masterson curette in sampling the endometrial cavity. Journal of the National Medical Association, 87(12), 877-880.
Reddington, L. ; Hernandez, E. ; Balsara, G. ; Hughes, D. ; Anderson, L. ; Heller, Paul. / The effectiveness of the Masterson curette in sampling the endometrial cavity. In: Journal of the National Medical Association. 1995 ; Vol. 87, No. 12. pp. 877-880.
@article{75df547b03d349a0a39a7c4dc137d73e,
title = "The effectiveness of the Masterson curette in sampling the endometrial cavity.",
abstract = "The Masterson curette was used to sample the endometrial cavity of 25 women prior to scheduled hysterectomy for benign or malignant pathology. Adequate amount of tissue was obtained in 20 (87{\%}) of 23 patients who did not have endometrial atrophy. The Masterson curettage detected all seven cases of endometrial hyperplasia or adenocarcinoma for a sensitivity of 100{\%}. However, the Masterson curette does not sample the entire endometrial cavity. If abnormal uterine bleeding persists despite normal histology on curettings obtained with the Masterson or other endometrial sampling device, hysteroscopy is recommended.",
author = "L. Reddington and E. Hernandez and G. Balsara and D. Hughes and L. Anderson and Paul Heller",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "87",
pages = "877--880",
journal = "Journal of the National Medical Association",
issn = "1943-4693",
publisher = "National Medical Association",
number = "12",

}

Reddington, L, Hernandez, E, Balsara, G, Hughes, D, Anderson, L & Heller, P 1995, 'The effectiveness of the Masterson curette in sampling the endometrial cavity.', Journal of the National Medical Association, vol. 87, no. 12, pp. 877-880.

The effectiveness of the Masterson curette in sampling the endometrial cavity. / Reddington, L.; Hernandez, E.; Balsara, G.; Hughes, D.; Anderson, L.; Heller, Paul.

In: Journal of the National Medical Association, Vol. 87, No. 12, 01.01.1995, p. 877-880.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effectiveness of the Masterson curette in sampling the endometrial cavity.

AU - Reddington, L.

AU - Hernandez, E.

AU - Balsara, G.

AU - Hughes, D.

AU - Anderson, L.

AU - Heller, Paul

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The Masterson curette was used to sample the endometrial cavity of 25 women prior to scheduled hysterectomy for benign or malignant pathology. Adequate amount of tissue was obtained in 20 (87%) of 23 patients who did not have endometrial atrophy. The Masterson curettage detected all seven cases of endometrial hyperplasia or adenocarcinoma for a sensitivity of 100%. However, the Masterson curette does not sample the entire endometrial cavity. If abnormal uterine bleeding persists despite normal histology on curettings obtained with the Masterson or other endometrial sampling device, hysteroscopy is recommended.

AB - The Masterson curette was used to sample the endometrial cavity of 25 women prior to scheduled hysterectomy for benign or malignant pathology. Adequate amount of tissue was obtained in 20 (87%) of 23 patients who did not have endometrial atrophy. The Masterson curettage detected all seven cases of endometrial hyperplasia or adenocarcinoma for a sensitivity of 100%. However, the Masterson curette does not sample the entire endometrial cavity. If abnormal uterine bleeding persists despite normal histology on curettings obtained with the Masterson or other endometrial sampling device, hysteroscopy is recommended.

UR - http://www.scopus.com/inward/record.url?scp=0029448760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029448760&partnerID=8YFLogxK

M3 - Article

C2 - 8558620

AN - SCOPUS:0029448760

VL - 87

SP - 877

EP - 880

JO - Journal of the National Medical Association

JF - Journal of the National Medical Association

SN - 1943-4693

IS - 12

ER -

Reddington L, Hernandez E, Balsara G, Hughes D, Anderson L, Heller P. The effectiveness of the Masterson curette in sampling the endometrial cavity. Journal of the National Medical Association. 1995 Jan 1;87(12):877-880.